GP

Gauravkumar Patel

Active Director Director/Designated Partner DIN 11771390
DIN 11771390 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Gauravkumar Patel

Gauravkumar Patel is a Director/Designated Partner at Comprehensive Organ Transplant Care Private Limited (since 2026).

DIN 11771390
Primary Designation Director/Designated Partner
First Appointment 01 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director/Designated Partner01 Jul 20262026Active

Board colleagues of Gauravkumar Patel

NameDINCompanyDesignation
Ripalben Gauravkumar Patel11771391Comprehensive Organ Transplant Care Private LimitedDirector/Designated Partner

Directorship timeline

Open interactive timeline →
Comprehensive Organ Transplant Care Private Limited
Premium access

Shareholding and investment profile for Gauravkumar Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gauravkumar Patel

Gauravkumar Patel currently holds 1 directorship: Comprehensive Organ Transplant Care Private Limited (Director/Designated Partner, since 01 Jul 2026).

Gauravkumar Patel was first appointed on 01 Jul 2026 as Director/Designated Partner at Comprehensive Organ Transplant Care Private Limited.

The current boards of Gauravkumar Patel's companies include Ripalben Gauravkumar Patel (Comprehensive Organ Transplant Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available